AQR Capital Management - NPS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
AQR Capital Management ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$5,054,000
+0.3%
141,291
-27.1%
0.01%
-21.4%
Q3 2014$5,038,000
-56.4%
193,751
-44.6%
0.01%
-54.8%
Q2 2014$11,566,000
+39.2%
349,951
+26.1%
0.03%
+24.0%
Q1 2014$8,307,000
-10.1%
277,551
-8.8%
0.02%
-10.7%
Q4 2013$9,240,000
+29.6%
304,351
+35.7%
0.03%
+12.0%
Q3 2013$7,132,000
+258.2%
224,211
+70.0%
0.02%
+257.1%
Q2 2013$1,991,000
-25.7%
131,857
-55.2%
0.01%
-36.4%
Q4 2012$2,680,000294,5380.01%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 549,425$16,680,0006.89%
Opaleye Management Inc. 205,000$5,945,000,0004.67%
Rhenman & Partners Asset Management AB 240,000$7,286,0002.85%
SECTORAL ASSET MANAGEMENT INC 1,774,919$53,887,0002.32%
Eventide Asset Management 242,700$7,368,0002.27%
OAK RIDGE INVESTMENTS LLC 2,713,717$82,389,0002.16%
First Light Asset Management, LLC 68,245$2,072,0001.76%
Broadfin Capital, LLC 400,000$12,144,0001.60%
Cupps Capital Management, LLC 748,175$22,714,0001.54%
FCG ADVISORS, LLC 70,651$2,145,0001.45%
View complete list of NPS PHARMACEUTICALS INC shareholders